Title : Antithrombotic Therapy for Secondary Prevention in Patients With Diabetes Mellitus and Coronary Artery Disease.

Pub. Date : 2016

PMID : 26984587






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The development of antiplatelet therapies associated with more potent oral platelet P2Y12receptor inhibition, including prasugrel and ticagrelor, as well as platelet inhibitors blocking alternative pathways, such as thrombin-mediated platelet inhibition with vorapaxar, may represent potential treatment options in DM patients. vorapaxar coagulation factor II, thrombin Homo sapiens